Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.
AIM:To assess the effect of Lactobacillus supplementation on Helicobacter pylori eradication rates and side effects of the triple therapy. METHODS:PubMed, Embase, Web of Science and Cochrane Library were searched for articles published up to July, 2019. Review Manager 5.3 and Stata 12.0 were used fo...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0223309 |
id |
doaj-003d2141a2d640af900f6d2154507653 |
---|---|
record_format |
Article |
spelling |
doaj-003d2141a2d640af900f6d21545076532021-03-03T21:12:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-011410e022330910.1371/journal.pone.0223309Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.Mingyang YuRongguang ZhangPeng NiShuaiyin ChenGuangcai DuanAIM:To assess the effect of Lactobacillus supplementation on Helicobacter pylori eradication rates and side effects of the triple therapy. METHODS:PubMed, Embase, Web of Science and Cochrane Library were searched for articles published up to July, 2019. Review Manager 5.3 and Stata 12.0 were used for statistical analyses. RESULTS:The initial database search resulted in 852 articles. Through exclusion and screening, 11 randomized controlled trials involving a total of 724 patients were finally included in this meta-analysis. The H. pylori elimination rate in the Lactobacillus supplement group was significantly higher than that in the control group (RR 1.16, 95% CI 1.08-1.25, P<0.0001). Subgroup analysis showed that the eradication rates were significantly enhanced in both adults and children group, and no significant difference was detected between Asia and Europe group. In addition, sub-analysis based on duration of Lactobacillus supplementation showed the pooled RRs in the long-term and short-term groups were 1.17 (95%CI 1.06-1.30) and 1.16 (95% CI 1.04-1.30), respectively. Regarding the Lactobacillus strains, the pooled RR was 1.33 (95% CI 1.10-1.62) in the L. casei group, 1.18 (95% CI 1.03-1.34) in the L. reuteri group while 1.02 (95% CI 0.87-1.21) in the Lactobacillus GG group. As for the total side effects, Lactobacillus supplementation significantly reduced the incidence of taste disturbance (RR = 0.36, 95% CI 0.17-0.74, P = 0.005). CONCLUSIONS:Lactobacillus supplementation during the treatment of Helicobacter pylori infection can effectively improve the eradication rates, and reduce the incidence of therapy-related taste disturbance.https://doi.org/10.1371/journal.pone.0223309 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mingyang Yu Rongguang Zhang Peng Ni Shuaiyin Chen Guangcai Duan |
spellingShingle |
Mingyang Yu Rongguang Zhang Peng Ni Shuaiyin Chen Guangcai Duan Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials. PLoS ONE |
author_facet |
Mingyang Yu Rongguang Zhang Peng Ni Shuaiyin Chen Guangcai Duan |
author_sort |
Mingyang Yu |
title |
Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials. |
title_short |
Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials. |
title_full |
Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials. |
title_fullStr |
Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials. |
title_full_unstemmed |
Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials. |
title_sort |
efficacy of lactobacillus-supplemented triple therapy for h. pylori eradication: a meta-analysis of randomized controlled trials. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2019-01-01 |
description |
AIM:To assess the effect of Lactobacillus supplementation on Helicobacter pylori eradication rates and side effects of the triple therapy. METHODS:PubMed, Embase, Web of Science and Cochrane Library were searched for articles published up to July, 2019. Review Manager 5.3 and Stata 12.0 were used for statistical analyses. RESULTS:The initial database search resulted in 852 articles. Through exclusion and screening, 11 randomized controlled trials involving a total of 724 patients were finally included in this meta-analysis. The H. pylori elimination rate in the Lactobacillus supplement group was significantly higher than that in the control group (RR 1.16, 95% CI 1.08-1.25, P<0.0001). Subgroup analysis showed that the eradication rates were significantly enhanced in both adults and children group, and no significant difference was detected between Asia and Europe group. In addition, sub-analysis based on duration of Lactobacillus supplementation showed the pooled RRs in the long-term and short-term groups were 1.17 (95%CI 1.06-1.30) and 1.16 (95% CI 1.04-1.30), respectively. Regarding the Lactobacillus strains, the pooled RR was 1.33 (95% CI 1.10-1.62) in the L. casei group, 1.18 (95% CI 1.03-1.34) in the L. reuteri group while 1.02 (95% CI 0.87-1.21) in the Lactobacillus GG group. As for the total side effects, Lactobacillus supplementation significantly reduced the incidence of taste disturbance (RR = 0.36, 95% CI 0.17-0.74, P = 0.005). CONCLUSIONS:Lactobacillus supplementation during the treatment of Helicobacter pylori infection can effectively improve the eradication rates, and reduce the incidence of therapy-related taste disturbance. |
url |
https://doi.org/10.1371/journal.pone.0223309 |
work_keys_str_mv |
AT mingyangyu efficacyoflactobacillussupplementedtripletherapyforhpylorieradicationametaanalysisofrandomizedcontrolledtrials AT rongguangzhang efficacyoflactobacillussupplementedtripletherapyforhpylorieradicationametaanalysisofrandomizedcontrolledtrials AT pengni efficacyoflactobacillussupplementedtripletherapyforhpylorieradicationametaanalysisofrandomizedcontrolledtrials AT shuaiyinchen efficacyoflactobacillussupplementedtripletherapyforhpylorieradicationametaanalysisofrandomizedcontrolledtrials AT guangcaiduan efficacyoflactobacillussupplementedtripletherapyforhpylorieradicationametaanalysisofrandomizedcontrolledtrials |
_version_ |
1714818140970418176 |